Antiarrhythmic Drug Use in the Blanking Period After Re‐Ablation and Recurrence in Paroxysmal Atrial Fibrillation
There was no significant relationship between AAD therapy during the blanking period after repeat ablation and AF recurrence at 12 months in patients with PAF.
Authors
- Changsheng Ma (ORCID: https://orcid.org/0000-0002-5387-5957)
- Haoming You
- Deyong Long (ORCID: https://orcid.org/0000-0003-4604-5346)
- Caihua Sang
- Sitong Li (ORCID: https://orcid.org/0000-0002-6306-2538)
- Chenxi Jiang (ORCID: https://orcid.org/0000-0001-9131-0589)
- Lu Zhou (ORCID: https://orcid.org/0000-0002-5023-8186)
- Jianzeng Dong (ORCID: https://orcid.org/0000-0001-7299-7805)
- Xueyuan Guo (ORCID: https://orcid.org/0000-0002-7533-1387)
- Ribo Tang (ORCID: https://orcid.org/0000-0003-2812-1827)
- Songnan Li (ORCID: https://orcid.org/0000-0002-3139-663X)
- Nian Liu (ORCID: https://orcid.org/0000-0002-3324-8606)
- Wei Wang (ORCID: https://orcid.org/0000-0002-5273-3332)
- Ning Zhou (ORCID: https://orcid.org/0009-0004-1993-1961)
- Xin Du (ORCID: https://orcid.org/0000-0001-7424-1438)
- Ronghui Yu (ORCID: https://orcid.org/0009-0002-7212-6203)
- Liu He (ORCID: https://orcid.org/0009-0007-2418-2389)
Institutions
- Capital Medical University (CN)
- UNSW Sydney (AU)
- The George Institute for Global Health (AU)
- Beijing Anzhen Hospital (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- Pacing and Clinical Electrophysiology
- Published
- 2025-04-02
- DOI
- https://doi.org/10.1111/pace.15181
- Citations
- 1
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- National Science Foundation
- National Natural Science Foundation of China
- National Key Research and Development Program of China